Project 3: Regulation of atheroprotective IgM - producing B cells in murine and human atherosclerosis
项目 3:调节小鼠和人类动脉粥样硬化中产生动脉粥样硬化 IgM 的 B 细胞
基本信息
- 批准号:10334096
- 负责人:
- 金额:$ 4.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-01 至 2022-06-02
- 项目状态:已结题
- 来源:
- 关键词:Anti-Inflammatory AgentsAntibodiesAntigensAtherosclerosisAttenuatedB-Cell Antigen ReceptorB-LymphocytesBlocking AntibodiesCCL20 geneCCR6 geneCXCR4 geneCell CommunicationCell physiologyCellsClinicalCoronary ArteriosclerosisCytometryDNA Sequencing FacilityDataDevelopmentDietDisease ProgressionDissectionEpitopesEventFlow CytometryFrequenciesHumanImmuneImmunizationImmunoglobulin MIn VitroInflammatoryKnock-outLesionLinkLow-Density LipoproteinsMS4A1 geneMalondialdehydeMediatingMembrane MicrodomainsMonoclonal AntibodiesMusPeripheral Blood Mononuclear CellPhenotypePlasmaProductionProteinsReceptor SignalingRegulationResearchSeverity of illnessSialoglycoproteinsSignal PathwaySignal TransductionSignaling MoleculeSpleenSurfaceTestingWorkatheroprotectiveburden of illnesschemokine receptorclinically relevantcohortcomplementarity-determining region 3cytokinegain of functionhigh dimensionalityhuman subjecthumanized mouseimprovedin vivoinnovationinsightmigrationmouse modelnoveloxidationreceptor functionsialic acid binding Ig-like lectintraffickingtranscriptome sequencing
项目摘要
Project 3 Summary
We and others have extensively studied B-1 cells in mice, clearly showing that these cells and
the IgM to oxidation-specific epitopes (OSE) on LDL (IgMOSE) that they produce are anti-
inflammatory and block atherosclerosis (AS) development. Yet, despite a wealth of evidence
that plasma levels of IgM to the OSE, malondialdehyde-modified LDL (IgMMDA-LDL) in humans
are associated with less CAD and fewer CV events, identification of the IgMMDA-LDL producing
human B cell has remained elusive. Our novel data from the previous cycle, utilizing the well
characterized CAVA cohort and high dimensional phenotyping of circulating B cells, are the first
to identify human B cell subtypes that produce IgMMDA-LDL, and demonstrate that they are indeed
associated with high plasma levels of IgMMDA-LDL and inversely correlated with CAD severity in
humans. One of these subtypes (B27+IgM+24hi cells) trafficked to the spleen and could be
stimulated by MDA antigen to produce higher levels of IgMMDA-LDL in vivo. Our findings revealed
the novel discovery that the sialogycoprotein, CD24, regulated expression of the chemokine
receptor CCR6 and splenic localization of these cells. CD24, a GPI-anchored
sialoglycoprotein that resides in lipid rafts and regulates signaling of the IgM BCR, has not
previously been implicated in murine or human AS. Utilizing our antibody and transcriptome
sequencing core (Core B), we discovered that B27+IgM+24hi cells express more CCR6 and IgM
specifically in subjects with low compared to high CAD and we identified signaling molecules
downstream of CCR6 and the IgM BCR associated with CAD severity. Accordingly, we
hypothesize that humans with severe CAD and rapid CAD progression have fewer
B27+IgM+24hi cells and that CD24 acts as a rheostat promoting key surface receptor function
and signaling pathways in B27+IgM+ cells leading to enhanced production of IgMOSE and
atheroprotection. We will utilize novel clinical cohorts (aim 1) and loss- and gain- of function
approaches in vitro and in vivo (aim 2) to define the mechanisms whereby CD24 regulates the
B27+IgM+ phenotype with particular emphasis on CCR6, the BCR, key signaling events and the
IgM repertoire in atherosclerosis.
项目3摘要
我们和其他人已经在小鼠中广泛研究了B-1细胞,清楚地表明这些细胞和
它们产生抗LDL上氧化特异性表位(OSE)的IgM(IgMOSE)是抗-
炎症和阻断动脉粥样硬化(AS)发展。然而,尽管有大量证据
人血浆中OSE、丙二醛修饰的低密度脂蛋白(IgMMDA-LDL)的IgM水平
与较少的CAD和较少的CV事件相关,
人类B细胞仍然是难以捉摸。我们从上一个周期获得的新数据,
特征性CAVA队列和循环B细胞的高维表型,是第一个
鉴定产生IgMMDA-LDL的人B细胞亚型,并证明它们确实是
与高血浆IgMMDA-LDL水平相关,与CAD严重程度呈负相关,
人类其中一种亚型(B27+IgM+24 hi细胞)被运输到脾脏,并可能被转移到淋巴细胞。
MDA抗原刺激产生更高水平的IgMMDA-LDL。我们的发现表明
唾液酸糖蛋白CD 24调节趋化因子表达的新发现
受体CCR 6和这些细胞的脾定位。CD 24,GPI锚定的
唾液酸糖蛋白存在于脂筏中并调节IgM BCR的信号传导,
先前与鼠或人AS有关。利用我们的抗体和转录组
测序核心(Core B),我们发现B27+IgM+24 hi细胞表达更多的CCR 6和IgM
特别是在低CAD与高CAD的受试者中,我们鉴定了信号分子,
CCR 6下游和IgM BCR与CAD严重程度相关。因此我们
假设患有严重CAD和快速CAD进展的人具有较少的
B27+IgM+24 hi细胞,CD 24作为变阻器促进关键表面受体功能
和B27+IgM+细胞中的信号传导途径,导致IgMOSE的产生增强,
动脉粥样硬化保护我们将利用新的临床队列(目标1)和功能的丧失和获得
在体外和体内的方法(目的2),以确定机制,其中CD 24调节
B27+IgM+表型,特别强调CCR 6、BCR、关键信号传导事件和
动脉粥样硬化中的IgM库。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Coleen A McNamara其他文献
406-5 Oxidized low-density lipoprotein-stimulated smooth muscle cell growth is mediated by the helix loop helix factor Id3: A novel mechanism contributing to atherosclerotic lesion formation
- DOI:
10.1016/s0735-1097(04)92264-4 - 发表时间:
2004-03-03 - 期刊:
- 影响因子:
- 作者:
Angela M Taylor;Feng Li;Ross Gerrity;Richard L Birnbaum;Martin Matsumura;Sarah Rutherford;Puspha-Rekha Thimmalapura;Coleen A McNamara - 通讯作者:
Coleen A McNamara
Coleen A McNamara的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Coleen A McNamara', 18)}}的其他基金
Id3 and VSMC in Murine and Human Atherosclerosis
Id3 和 VSMC 在小鼠和人类动脉粥样硬化中的作用
- 批准号:
10004164 - 财政年份:2019
- 资助金额:
$ 4.31万 - 项目类别:
Id3 and VSMC in Murine and Human Atherosclerosis
Id3 和 VSMC 在小鼠和人类动脉粥样硬化中的作用
- 批准号:
10421070 - 财政年份:2019
- 资助金额:
$ 4.31万 - 项目类别:
Id3 and VSMC in Murine and Human Atherosclerosis
Id3 和 VSMC 在小鼠和人类动脉粥样硬化中的作用
- 批准号:
10210435 - 财政年份:2019
- 资助金额:
$ 4.31万 - 项目类别:
Somatic TET2 mutation-driven clonal hematopoiesis in atherosclerosis
动脉粥样硬化中体细胞 TET2 突变驱动的克隆造血
- 批准号:
10397523 - 财政年份:2018
- 资助金额:
$ 4.31万 - 项目类别:
Somatic TET2 mutation-driven clonal hematopoiesis in atherosclerosis
动脉粥样硬化中体细胞 TET2 突变驱动的克隆造血
- 批准号:
9913594 - 财政年份:2018
- 资助金额:
$ 4.31万 - 项目类别:
B Cell Subsets in Mouse and Human Atherosclerosis
小鼠和人类动脉粥样硬化中的 B 细胞亚群
- 批准号:
10188607 - 财政年份:2017
- 资助金额:
$ 4.31万 - 项目类别:
Genetic Regulation of B Lymphocyte Aortic Homing and Atheroprotection
B 淋巴细胞主动脉归巢和动脉粥样硬化的基因调控
- 批准号:
8433454 - 财政年份:2011
- 资助金额:
$ 4.31万 - 项目类别:
Genetic Regulation of B Lymphocyte Aortic Homing and Atheroprotection
B 淋巴细胞主动脉归巢和动脉粥样硬化的基因调控
- 批准号:
8607987 - 财政年份:2011
- 资助金额:
$ 4.31万 - 项目类别:
Genetic Regulation of B Lymphocyte Aortic Homing and Atheroprotection
B 淋巴细胞主动脉归巢和动脉粥样硬化的基因调控
- 批准号:
8243525 - 财政年份:2011
- 资助金额:
$ 4.31万 - 项目类别:
Genetic Regulation of B Lymphocyte Aortic Homing and Atheroprotection
B 淋巴细胞主动脉归巢和动脉粥样硬化的基因调控
- 批准号:
8083888 - 财政年份:2011
- 资助金额:
$ 4.31万 - 项目类别:
相似海外基金
Rationally guided discovery platform for monoclonal antibodies against carbohydrate antigens using virus-like particle conjugate immunization and high throughput selection
使用病毒样颗粒缀合物免疫和高通量选择的合理引导的针对碳水化合物抗原的单克隆抗体的发现平台
- 批准号:
10574738 - 财政年份:2023
- 资助金额:
$ 4.31万 - 项目类别:
Assessing the role of liver stage antigens-specific antibodies against Plasmodium falciparum liver stage infection
评估肝期抗原特异性抗体对抗恶性疟原虫肝期感染的作用
- 批准号:
10392870 - 财政年份:2021
- 资助金额:
$ 4.31万 - 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
- 批准号:
10092930 - 财政年份:2020
- 资助金额:
$ 4.31万 - 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
- 批准号:
9896170 - 财政年份:2020
- 资助金额:
$ 4.31万 - 项目类别:
Interrogation of cell surface antigens on B lineage cells using structurally unique variable lymphocyte receptor antibodies of the evolutionarily distant sea lamprey
使用进化遥远的海七鳃鳗结构独特的可变淋巴细胞受体抗体询问 B 谱系细胞上的细胞表面抗原
- 批准号:
433456 - 财政年份:2020
- 资助金额:
$ 4.31万 - 项目类别:
Operating Grants
Investigations of interactions between various natural antibodies and food-derived antigens
研究各种天然抗体与食物源性抗原之间的相互作用
- 批准号:
19K15765 - 财政年份:2019
- 资助金额:
$ 4.31万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Identifying Kawasaki Disease-Specific Antibodies and Antigens
识别川崎病特异性抗体和抗原
- 批准号:
9932769 - 财政年份:2018
- 资助金额:
$ 4.31万 - 项目类别:
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
- 批准号:
BB/P504713/1 - 财政年份:2017
- 资助金额:
$ 4.31万 - 项目类别:
Training Grant
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
- 批准号:
1932904 - 财政年份:2017
- 资助金额:
$ 4.31万 - 项目类别:
Studentship
SBIR Phase II: Automated Design Methods of Antibodies Directed to Protein and Carbohydrate Antigens
SBIR II 期:针对蛋白质和碳水化合物抗原的抗体的自动化设计方法
- 批准号:
1632399 - 财政年份:2016
- 资助金额:
$ 4.31万 - 项目类别:
Standard Grant